Order above $2000 or more and get $50 off on your first order by using promo code "WELCOME"
Nature Bounty A2z Tablets (1 Bottle = 30 Tablets)
₹375.00 Original price was: ₹375.00.₹356.20Current price is: ₹356.20.
- Variations: Bottle
- Discount Amount On Bottle: £18.8
- Prescription Required: Optional
- Bottle: £376.0
- Used For: Multivitamins
- Brand: Nature Bounty
- Min Order Quantity: 30 units
- Min Order Price: ₹11250.00
SKU:
53817
Category: Nutritions & Supplements
Description
Nature’s Bounty A2Z Tablets: Your Comprehensive Health Solution
Discover the ultimate health support with Nature’s Bounty A2Z Tablets. Each bottle contains 30 tablets, designed to provide a broad spectrum of essential nutrients for overall well-being. Whether you’re looking to boost your immune system, support heart health, or simply maintain your natural vitality, these tablets are your go-to solution. With their high-quality formula and 50+ years of scientific backing, you can trust Nature’s Bounty to help you live your best life.
Reviews (0)
Be the first to review “Nature Bounty A2z Tablets (1 Bottle = 30 Tablets)” Cancel reply
Shipping & Delivery
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
Ginsoden Tablets (1 Bottle = 30 Tablets)
₹10,800.00
Reviews
There are no reviews yet.